Renalytix (Reg S) (RENX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 5.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 11.50
  • 52 Week Low: 5.62
  • Currency: UK Pounds
  • Shares Issued: 437.02m
  • Volume: 0
  • Market Cap: £25.13m
  • RiskGrade: 348

Latest Deals

Traded Action Notifier PriceAmountValue
26-Sep-25 Placing Robert (Rob) Graham Naylor 9.50p 105,263 £9,999.98
26-Sep-25 Placing Catherine Coste 9.50p 105,263 £9,999.98
26-Sep-25 Placing Christopher H B Mills 9.50p 2,500,000 £237,500.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
26-Sep-25 Placing Christopher H B Mills 9.50p 2,500,000 £237,500.00
26-Sep-25 Placing Catherine Coste 9.50p 105,263 £9,999.98
26-Sep-25 Placing Robert (Rob) Graham Naylor 9.50p 105,263 £9,999.98

Director Shareholdings

Notifier Holding Value*
Christopher H B Mills 17,061,345 £981,027
James Renwick McCullough 3,242,096 £186,420
Robert (Rob) Graham Naylor 693,318 £39,866
Fergus Fleming 569,481 £32,745
Catherine Coste 385,129 £22,145

Major Shareholders

Notifier** Holding Value*
Heights Capital Management, Inc. 43,151,533 £2,481,213
CVI Holdings, LLC 43,151,533 £2,481,213
Pentwater Capital Management LP 34,049,049 £1,957,820
UBS Group AG 33,349,947 £1,917,622
Ruffer LLP 32,800,000 £1,886,000
UBS Group AG 32,565,952 £1,872,542
Jefferson River Capital LLC 30,755,501 £1,768,441
Unicorn Asset Management Limited 25,797,882 £1,483,378
Harwood Capital LLP 17,061,345 £981,027
Harwood Capital LLP 14,609,946 £840,072
ABRDN World Healthcare Fund 14,546,533 £836,426
Vaal Investment Partners 13,827,903 £795,104
Polar Capital, LLP 13,196,197 £758,781
Icahn School of Medicine at Mount Sinai 10,750,926 £618,178
Mount Sinai 8,018,986 £461,092
Gilder Gagnon Howe and Co LLC 6,042,634 £347,452
Forest Nominees Limited 4,001,187 £230,068
Lombard Odier & Co Ltd 2,952,334 £169,759
Amati Global Investors 2,455,247 £141,177
Fidelity Investment International 2,173,851 £124,996

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

RENX Market Data

Currency UK Pounds
Share Price 5.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 11.50
52 Week Low 5.62
Volume 0
Shares Issued 437.02m
Market Cap £25.13m
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

RENX Dividends

No dividends found

Trades for --2026

Time Volume / Share Price
0 @ 0.000p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page